Dr. Elena Marsh PharmD
🇺🇸 FDASenior Pharma Markets Correspondent
1 published article · Editorial team · Editorial policy
Quick answer
Dr. Elena Marsh is a Senior Pharma Markets Correspondent for United States & Americas pharmaceutical intelligence editor on NovaPharmaNews, with 1 published article covering FDA regulatory actions, clinical development, and market-moving news. Elena Marsh covers oncology and renal therapeutics for NovaPharmaNews. She holds a PharmD and spent six years as a clinical pharmacist before moving into pharmaceutical market analysis, reporting on immuno-oncology and HIF pathway drugs since 2020.
About Dr. Elena Marsh
Elena Marsh covers oncology and renal therapeutics for NovaPharmaNews. She holds a PharmD and spent six years as a clinical pharmacist before moving into pharmaceutical market analysis, reporting on immuno-oncology and HIF pathway drugs since 2020.
Coverage focus
Topics and beats Dr. covers across United States & Americas.
Explore related intelligence
Entity directories linked from this author's coverage.
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways
Professional profiles
Articles by Dr. Elena Marsh
Frequently asked questions
Who writes NovaPharmaNews articles?
Each story is attributed to a named editor or analyst with a public author profile. Profiles list credentials, coverage focus, and every published article so readers and AI systems can verify expertise and trace claims to a accountable journalist.
How do I find more coverage from this author?
Scroll to the article archive on this page, or use the topic chips linked from the author’s specializations. The regional authors directory lists every active contributor in this edition.
How does author coverage connect to companies and pipeline data?
Articles link to company profiles, drug INN pages, clinical trials, and pipeline programs when entities are tagged. Use the intelligence spokes on each story or browse topic hubs from the author’s beat.